- 1 226
- 6 729
PRECISCA
United States
เข้าร่วมเมื่อ 13 ต.ค. 2023
Welcome to PrecisCa - Your Trusted Source for Oncology 2nd Opinions.
At PrecisCa, we are dedicated to providing expert second opinions to community Oncologists for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, complex patient case panel discussions, treatment options, patient stories, and the latest advancements in cancer research. Whether you're looking for something case specific, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: www.PrecisCa.com for more detailed information and personalized second opinions.
At PrecisCa, we are dedicated to providing expert second opinions to community Oncologists for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, complex patient case panel discussions, treatment options, patient stories, and the latest advancements in cancer research. Whether you're looking for something case specific, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: www.PrecisCa.com for more detailed information and personalized second opinions.
Expert Cancer Panel: Metastatic thymoma w/ partial response from front-line combination chemotherapy
Recorded on 6/12/2021
43-year-old female with metastatic thymoma demonstrating a partial response with frontline combination chemotherapy
Summary:
- Next line therapy after partial response to CAP chemotherapy would include pembrolizumab or switching to carboplatin/paclitaxel
- Immune related adverse events like myocarditis limit utility of immunotherapy however
- Conventionally fractionated radiation to the primary with stereotactic body radiation therapy to the pulmonary metastases is an appropriate aggressive strategy
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
43-year-old female with metastatic thymoma demonstrating a partial response with frontline combination chemotherapy
Summary:
- Next line therapy after partial response to CAP chemotherapy would include pembrolizumab or switching to carboplatin/paclitaxel
- Immune related adverse events like myocarditis limit utility of immunotherapy however
- Conventionally fractionated radiation to the primary with stereotactic body radiation therapy to the pulmonary metastases is an appropriate aggressive strategy
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
มุมมอง: 0
วีดีโอ
Expert Cancer Panel: Stage 3 thymic carcinoma presenting for determination of front-line therapy
มุมมอง 22 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 56-year-old male with stage 3 thymic carcinoma presenting for determination of frontline therapy Summary: - Neoadjuvant concurrent chemoradiation with carboplatin/paclitaxel followed by surgical resection of locally advanced thymic carcinoma is recommended - Alternatively, you could offer neoadjuvant CAP chemotherapy followed by surgery - Consolidative immunotherapy such a...
Expert Cancer Panel: Metastatic epithelioid mesothelioma w/ progression on first-line chemotherapy
มุมมอง 32 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 77-year-old male, former smoker with metastatic epithelioid mesothelioma with progression on first-line chemotherapy Summary: - Next-line therapy would include single agent pembrolizumab or combination ipilimumab/nivolumab immunotherapy - Continuing carboplatin/pemetrexed or a trial of single agent chemotherapy is not recommended - Surveillance imaging and observation with...
Expert Cancer Panel: EGFR+ lung adenocarcinoma, on osimertinib but stopped due to pneumonitis
มุมมอง 22 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 63-year-old female with lung adenocarcinoma, EGFR. Osimertinib stopped due to pneumonitis and BIPAP support, now recovered Summary: - Stage IV lung adenocarcinoma with EGFR exon 19 deletion with severe drug-induced pneumonitis should be treated with carboplatin/pemetrexed - Avoid challenging with future immune checkpoint inhibitor or other EGFR tyrosine kinase inhibitors -...
Expert Cancer Panel: pT1bN0M0 SCC of RLL s/p lobectomy with local recurrence with no mets; PD-L1 70%
2 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 62-year-old female, current smoker ( greater than 40 pack years), with history of pT1bN0M0 squamous cell carcinoma of the right lower lobe status post lobectomy with recurrence after 2 years in right hilum with no metastatic disease; PD-L1 70%, other mutations negative Summary: - For patients with locally recurrent squamous cell carcinoma of the hilum after lobectomy, conc...
Expert Cancer Panel: Stage IV SCC of lung s/p chemo, RT and IO with widespread disease; PD-L1 40%
2 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 73-year-old, reformed smoker (40 pack years), with history of stage IV squamous cell carcinoma of the lung with malignant pleural effusion status post 4 cycles carboplatin/paclitaxel, palliative thoracic radiation therapy followed by nivolumab monotherapy for 5 cycles, now presenting with widespread progressive disease; PD-L1 40%, other mutations negative Summary: - After ...
Expert Cancer Panel: Stage II adenosquamous carcinoma s/p resection with positive margins
มุมมอง 42 ชั่วโมงที่ผ่านมา
Recorded on 6/12/2021 74-year-old female, current smoker (50 pack years), with diagnosis of stage II adenosquamous carcinoma of the right upper lobe status post wedge resection with positive margins. PD-L1 greater than 1%, other mutations negative Summary: - After a positive margin wedge resection for pT3N0 adenosquamous lung cancer, adjuvant conventionally fractionated radiation is appropriate...
Expert Cancer Panel: Unresectable lung neuroendocrine tumor with progression after octreotide and RT
มุมมอง 32 ชั่วโมงที่ผ่านมา
Recorded on 5/22/2021 61-year-old male with unresectable lung neuroendocrine tumor and disease progression following octreotide/radiotherapy Summary: - Palliative radiotherapy may be performed for symptomatic pleural carcinoid metastases; if possible, a hypofractionated radiotherapy approach with SBRT would be more effective - The panel recommends against continuing palliative octreotide due to...
Expert Cancer Panel: Stage III atypical carcinoid of mediastinum resected w/ clear margins
มุมมอง 42 ชั่วโมงที่ผ่านมา
Recorded on 5/22/2021 46-year-old male found to have stage III atypical carcinoid tumor of the mediastinum resected with negative margins Summary: - The backbone of therapy for thoracic neuroendocrine tumor is surgical resection. - In the case of close surgical margins, intra operative biopsies of nearby structures may be performed to evaluate the extent of tumor spread. - Adjuvant radiation is...
Expert Cancer Panel: Stage IV lung adenocarcinoma, PD-L1 greater than 50%, with SD
2 ชั่วโมงที่ผ่านมา
Recorded on 5/22/2021 64-year-old male with stage IV lung adenocarcinoma, PD-L1 greater than 50%, with stable disease on second-line atezolizumab Summary: - SBRT will provide more effective symptom relief for osseous metastases; however, a single fraction 8 Gy dose to the affected area is still effective and can be performed more quickly if indicated - The panel recommends continuing atezolizum...
Expert Cancer Panel: Stage IV lung cancer with EGFR exon 19 del, progressed on several treatments
มุมมอง 12 ชั่วโมงที่ผ่านมา
Recorded on 5/22/2021 60-year-old female with stage IV lung adenocarcinoma with EGFR exon 19 deletion progressed on several lines of therapy Summary: - Re-biopsy. This could reveal new therapeutic targets that have evolved since last biopsy. - Clinical trial. Likely the best option for this patient given extensive prior treatment. - Immunotherapy. Minimal efficacy as a monotherapy but could int...
Expert Cancer Panel: Stage IV SCC of the lung, PD-L1 negative, with painful lymphadenopathy
มุมมอง 52 ชั่วโมงที่ผ่านมา
Recorded on 5/22/2021 66-year-old male with stage IV squamous cell carcinoma of the lung, PD-L1 negative, with painful lymphadenopathy Summary: - For patients with metastatic NSCL with a single painful bone sight, systemic therapy is often given concurrently with palliative radiation. - Keynote-407 established carboplatin plus either paclitaxel or nab-paclitaxel plus pembrolizumab as a preferre...
Expert Cancer Panel: Limited stage SCLC with localized nodal recurrence after chemoradiation
มุมมอง 12 ชั่วโมงที่ผ่านมา
Recorded on 5/8/2021 60-year-old female with limited stage small cell lung cancer and localized nodal recurrence after chemoradiation Summary: - Recommend upfront treatment strategy of concurrent chemoradiation with platinum and etoposide. - For radiotherapy dose and fractionation, recommend either 45 Gy BID or 60 Gy daily - At time of recurrence, consider a re-challenge with platinum and etopo...
Expert Cancer Panel: Stage II lung adenocarcinoma treated with chemoradiation with recurrent disease
2 ชั่วโมงที่ผ่านมา
Recorded on 5/8/2021 62-year-old male with stage II lung adenocarcinoma initially treated with chemoradiation, now with recurrent disease Summary: - In the setting of medically operable recurrent disease with limited nodal involvement, surgical salvage is the standard of care as reirradiation carries risks - Concurrent carboplatin/paclitaxel with radiotherapy may be considered in patients with ...
Expert Cancer Panel: WHO type B1 thymoma with positive margins following resection
2 ชั่วโมงที่ผ่านมา
Recorded on 5/8/2021 30-year-old female with WHO type B1 thymoma with positive surgical margins following resection Summary: - The addition of adjuvant radiation is recommended to address positive surgical margins at a standard dose and fractionation. - Systemic therapy is not recommended in the adjuvant setting in this case. - A period of 10 years is recommended for surveillance follow up for ...
Expert Cancer Panel: Stage IIIC superior sulcus tumor w/ extension to rib and PET-avid supraclav LN
มุมมอง 24 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IIIC superior sulcus tumor w/ extension to rib and PET-avid supraclav LN
Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule
มุมมอง 14 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule
Expert Cancer Panel: Newly diagnosed stage IV lung adenocarcinoma, EGFR mutation positive
มุมมอง 14 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Newly diagnosed stage IV lung adenocarcinoma, EGFR mutation positive
Expert Cancer Panel: Recurrent adenocarcinoma s/p pneumectomy, RT and SBRT, currently on osimertinib
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Recurrent adenocarcinoma s/p pneumectomy, RT and SBRT, currently on osimertinib
Expert Cancer Panel: Stage IVA lung cancer, PD-L1+, KRAS G12C, with single brain met s/p craniotomy
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IVA lung cancer, PD-L1 , KRAS G12C, with single brain met s/p craniotomy
Expert Cancer Panel: Stage IIB adenosquamous carcinoma w/ mets to ribs following definitive therapy
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IIB adenosquamous carcinoma w/ mets to ribs following definitive therapy
Expert Cancer Panel: Recurrent lung adenocarcinoma positive for MET exon 14 mutation s/p surgery
มุมมอง 64 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Recurrent lung adenocarcinoma positive for MET exon 14 mutation s/p surgery
Expert Cancer Panel: Lung adenocarcinoma s/p NAC and surgery w/ final pathology ypT1aN2M0
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Lung adenocarcinoma s/p NAC and surgery w/ final pathology ypT1aN2M0
Expert Cancer Panel: Front-line management of clinical stage I NSCLC
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Front-line management of clinical stage I NSCLC
Expert Cancer Panel: Stage IIB lung adenocarcinoma presenting for adjuvant therapy s/p lobectomy
มุมมอง 24 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IIB lung adenocarcinoma presenting for adjuvant therapy s/p lobectomy
Expert Cancer Panel: Stage IVA neuroendocrine lung carcinoma s/p bi-lobectomy
มุมมอง 34 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IVA neuroendocrine lung carcinoma s/p bi-lobectomy
Expert Cancer Panel: Extensive stage SCLC w/ SVC syndrome and brain metastases
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Extensive stage SCLC w/ SVC syndrome and brain metastases
Expert Cancer Panel: Stage IIA thymoma s/p surgery w/ close margins & microscopic capsular invasion
มุมมอง 74 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IIA thymoma s/p surgery w/ close margins & microscopic capsular invasion
Expert Cancer Panel: Completely resected stage IIIA SCLC, initially staged as adenocarcinoma
4 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Completely resected stage IIIA SCLC, initially staged as adenocarcinoma
Expert Cancer Panel: Stage IIA superior sulcus tumor (PD-L1 2%) w/ PET-avid LNs negative on EBUS
มุมมอง 34 ชั่วโมงที่ผ่านมา
Expert Cancer Panel: Stage IIA superior sulcus tumor (PD-L1 2%) w/ PET-avid LNs negative on EBUS
Thank you Dr. Donahue for all you have done for me.
Dr. Donahue saved my life. He is the most amazing and brilliant surgeon. I feel so fortunate that he performed my whipple surgery. That was over six years ago and I remain cancer free. Not only that, I’m betting he got an A in Bedside Manner 101 in medical school. He is just wonderful.
This woman rocks!
Dr. Pishvaian has an excellent background in medical genetics, and as a molecular biologist, I hope to have the opportunity to work with him one day.
thanks you for information
Thank you
thank you for providing this amazing videos